Approval of 45mg/0.5mL solution in a single-dose vial for subcutaneous injection expands dosing flexibility for pediatric patients with p ...

Alternative for treatment failure: parenteral therapy (home or hospital); sputum culture-based or adjusted therapy; consider referral to specialist Group III (suppurative CB) First-line oral ...

“Patients with COPD who have type 2 inflammation can benefit from biologic therapy, regardless of the severity of underlying airflow obstruction with or without the absence of chronic bronchitis ...

The rising burden of chronic diseases, the development of multi-slice CT scanners with faster imaging speeds and reduced radiation doses, the growing aging population, and the expansion of ...

Knowing how acute and chronic stress look and feel can help you better overcome them when they strike, mental health experts say. Are you a stress eater? Many people turn to food when they're ...

SiteOne’s STC-004 intends to address a highly pressing need to treat chronic pain without the potential of addiction and side effects associated with conventionally used opioids. “The global burden of ...

“This is the result of a long, constructive set of negotiations to try and get to something that really works,” said Merrill Gay, the executive director of the CT Early Childhood Alliance.

FDA approves Dupixent for chronic obstructive pulmonary disease Oct 2, 2024 Second Phase 3 clinical trial again shows dupilumab lessens disease in COPD patients with type 2 inflammation ...

Bronchitis involves inflammation of the bronchi, which are the tubes leading to the lungs. It can be acute or chronic. Acute bronchitis often results from a virus, and it typically lasts up to 10 ...

People are surprised to find we have some of the worst air on the East Coast,’’ said Ruth Canovi, advocacy director for the American Lung Association of Connecticut.

At its May 29 meeting, the Jericho Board of Education placed a spotlight on the district’s ongoing challenge with chronic absenteeism, unveiling data and laying out new strategies to curb the issue.